Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
Case History
Medical reports
Title
Created Date
Low-grade Non-Hodgkin Lymphoma at advanced stage: case report
17 November 2013
High-grade non-Hodgkin's lymphoma: case report
17 October 2013
Neuroblastoma: Complete objective response to biological treatment
28 July 2013
Oesophageal squamocellular carcinoma: a complete and objective response
09 July 2013
Advanced Lung Adenocarcinoma and Low Performance Status: study on 23 patients
26 June 2013
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
02 June 2013
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
22 May 2013
Complete objective response to biological therapy of plurifocal breast carcinoma
06 May 2013
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer
27 March 2013
Di Bella Method's improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of Lymphomas
10 February 2013
Display #
5
10
15
20
25
30
50
100
All
Page 2 of 3
Start
Prev
1
2
3
Next
End
Search
Follow us...
Latest
Dynamic properties of the growth hormone releasing hormone receptor (GHRHR) and molecular determinants of GHRH binding
Combination Treatment of Retinoic Acid Plus Focal Adhesion Kinase Inhibitor Prevents Tumor Growth and Breast Cancer Cell Metastasis
Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats
About melatonin - 1996
Inhibition of autophagy triggers melatonin-induced apoptosis in glioblastoma cells
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial
Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study
The Role of Melatonin in Colorectal Cancer
Therapeutic uses of somatostatin and its analogues: Current view and potential applications
Use of Melatonin in Cancer Treatment: Where Are We?
Role of Growth Hormone in Breast Cancer
Hormones and growth factors regulate telomerase activity in ageing and cancer
Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
Somatostatin Analog Therapy in Small Cell Lung Cancer
Melatonin and its ubiquitous anticancer effects
The role of prolactin and growth hormone in breast cancer
Targeting growth hormone in cancer: future perspectives
Most Read
The Di Bella Method (DBM)
All-trans-retinoic acid and cancer
About melatonin - 1996
Biography
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Somatostatin in oncology, the overlooked evidences
Bibliography
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
How effective is chemo therapy?
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Complete objective response to biological therapy of plurifocal breast carcinoma
Vademecum
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Di Bella Method's improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of Lymphomas
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients